Literature DB >> 3261826

Total pharyngolaryngectomy and cervical esophagectomy with jejunal autotransplant reconstruction: complications and results.

J L Ferguson1, L W DeSanto.   

Abstract

Eighteen patients underwent pharyngoesophageal reconstruction with a free jejunal autotransplant in a one-stage procedure after circumferential resection for cancer of the pharynx and cervical esophagus. Of these, six had minor complications (fistulas) and six had major complications including abdominal bleeding, cervical bleeding, graft failure, and one surgical death. The mean survival was 427 days after resection and reconstruction (range, 120 to 866 days). Ten patients died of their disease, and four died of other causes. The site of failure was local in five and distant in five. In view of this high complication rate and unimpressive survival rate, the use of other lower-morbidity reconstructive options or staged procedures may need to be considered in poor surgical candidates.

Entities:  

Mesh:

Year:  1988        PMID: 3261826     DOI: 10.1288/00005537-198809000-00001

Source DB:  PubMed          Journal:  Laryngoscope        ISSN: 0023-852X            Impact factor:   3.325


  3 in total

1.  Intraoperative endoscopy in obstructive hypopharyngeal carcinoma.

Authors:  Predrag Pesko; Milos Bjelovic; Predrag Sabljak; Dejan Stojakov; Ebrahimi Keramatollah; Dejan Velickovic; Bratislav Spica; Branka Nenadic; Aleksandra Djuric-Stefanovic; Djordjije Saranovic; Vera Todorovic
Journal:  World J Gastroenterol       Date:  2006-07-28       Impact factor: 5.742

2.  Evaluation of blood flow by color Doppler sonography in free jejunal interposition grafts for cervical esophageal reconstruction.

Authors:  Masakatsu Ueno; Harushi Osugi; Shigefumi Suehiro; Yoshihiko Nishimura; Nobuyasu Takada; Masashi Takemura; Hiroaki Kinoshita
Journal:  World J Surg       Date:  2005-03       Impact factor: 3.352

Review 3.  Role of autophagy in tumor response to radiation: Implications for improving radiotherapy.

Authors:  Amrita Roy; Soumen Bera; Luciano Saso; Bilikere S Dwarakanath
Journal:  Front Oncol       Date:  2022-09-12       Impact factor: 5.738

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.